Orthofix Medical Inc (OFIX)
13.76
-0.46
(-3.24%)
USD |
NASDAQ |
May 31, 16:00
13.73
-0.03
(-0.21%)
After-Hours: 20:00
Orthofix Medical Cash from Financing (Quarterly): 21.45M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 21.45M |
December 31, 2023 | 25.28M |
September 30, 2023 | 18.25M |
June 30, 2023 | 5.808M |
March 31, 2023 | 15.98M |
December 31, 2022 | 1.498M |
September 30, 2022 | -0.252M |
June 30, 2022 | 0.909M |
March 31, 2022 | -2.233M |
December 31, 2021 | 2.052M |
September 30, 2021 | 0.855M |
June 30, 2021 | -7.638M |
March 31, 2021 | 1.11M |
December 31, 2020 | 2.662M |
September 30, 2020 | -101.34M |
June 30, 2020 | 101.60M |
March 31, 2020 | 0.315M |
December 31, 2019 | 1.922M |
September 30, 2019 | -1.029M |
June 30, 2019 | -1.185M |
March 31, 2019 | -10.40M |
December 31, 2018 | 0.005M |
September 30, 2018 | -0.697M |
June 30, 2018 | -0.012M |
March 31, 2018 | 3.697M |
Date | Value |
---|---|
December 31, 2017 | 0.94M |
September 30, 2017 | 0.167M |
June 30, 2017 | 0.634M |
March 31, 2017 | 1.797M |
December 31, 2016 | -8.45M |
September 30, 2016 | -6.812M |
June 30, 2016 | -9.128M |
March 31, 2016 | -21.72M |
December 31, 2015 | -9.642M |
September 30, 2015 | -1.754M |
June 30, 2015 | 27.19M |
March 31, 2015 | 8.938M |
December 31, 2014 | 0.288M |
September 30, 2014 | -8.642M |
June 30, 2014 | -21.92M |
March 31, 2014 | 10.07M |
December 31, 2013 | -0.985M |
September 30, 2013 | -13.48M |
June 30, 2013 | -17.96M |
March 31, 2013 | -5.935M |
December 31, 2012 | 45.64M |
September 30, 2012 | -2.362M |
June 30, 2012 | -151.94M |
March 31, 2012 | -28.92M |
December 31, 2011 | -12.17M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-101.34M
Minimum
Sep 2020
101.60M
Maximum
Jun 2020
4.301M
Average
1.304M
Median
Cash from Financing (Quarterly) Benchmarks
Boston Scientific Corp | 1.569B |
Perspective Therapeutics Inc | 166.33M |
Xtant Medical Holdings Inc | 5.179M |
Asensus Surgical Inc | 0.811M |
Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -18.60M |
Cash from Investing (Quarterly) | -10.87M |
Free Cash Flow | -91.36M |
Free Cash Flow Per Share (Quarterly) | -0.7793 |
Free Cash Flow to Equity (Quarterly) | -53.25M |
Free Cash Flow to Firm (Quarterly) | -24.74M |
Free Cash Flow Yield | -17.84% |